Rankings
▼
Calendar
CRIS Q4 2017 Earnings — Curis, Inc. Revenue & Financial Results | Market Cap Arena
CRIS
Curis, Inc.
$14M
Q4 2017 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$3M
+38.1% YoY
Gross Profit
$3M
94.9% margin
Operating Income
-$7M
-218.5% margin
Net Income
-$8M
-246.1% margin
EPS (Diluted)
$-5.43
QoQ Revenue Growth
+33.5%
Cash Flow
Operating Cash Flow
-$8M
Free Cash Flow
-$8M
Stock-Based Comp.
$1M
Balance Sheet
Total Assets
$74M
Total Liabilities
$50M
Stockholders' Equity
$24M
Cash & Equivalents
$38M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$3M
$2M
+38.1%
Gross Profit
$3M
$2M
+38.2%
Operating Income
-$7M
-$11M
+33.8%
Net Income
-$8M
-$11M
+29.2%
← FY 2017
All Quarters
Q1 2018 →